A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 10, 2020

Primary Completion Date

October 7, 2020

Study Completion Date

October 7, 2020

Conditions

Healthy Participants

Interventions

DRUG

BMS-986278 Tablet

Specified dose on specified days

DRUG

Esomeprazole

Specified dose on specified days

DRUG

BMS-986278 suspension

Specified dose on specified days

Trial Locations (1)

ICON (LPRA) - Salt Lake, Salt Lake City